Opening GPAtlas…

๐ŸŒŠ The Ocean Library ยท GP clinical topic

Platelets - abnormal counts (Thrombocytosis and Thrombocytopenia)

Written and reviewed by practising UK GPs, overseen by our Clinical Advisory Officer. Last updated 21 Jan 2026.

๐Ÿงญ When to suspect

The platelet count is one of the most common abnormalities a GP meets on a full blood count (FBC), and the great majority are incidental and benign. The skill is to separate a transient, reactive change from the minority that signal serious disease โ€“ occult cancer, a myeloproliferative neoplasm (MPN), or a bleeding risk that needs same-day action.

Thrombocytosis (platelets > 450 ร— 10โน/L) is most often reactive โ€“ to infection, inflammation, tissue damage, iron deficiency, or malignancy. The key primary-care point is that a raised platelet count is a NICE-recognised marker of occult cancer, with a positive predictive value above the 3% threshold that mandates investigation. Persistent, unexplained thrombocytosis also raises the possibility of essential thrombocythaemia (ET) and other MPNs. Suspect on an incidental result, or with headache, visual disturbance, burning pain in the hands or feet (erythromelalgia), abnormal bleeding, or unprovoked thrombosis.

Thrombocytopenia (platelets < 150 ร— 10โน/L) presents with bruising, a petechial (non-blanching) rash, mucosal bleeding such as epistaxis or menorrhagia, or โ€“ commonly โ€“ as an incidental finding. Frequent causes are viral infection, drugs, alcohol excess, liver disease, pregnancy (gestational thrombocytopenia), and immune thrombocytopenia (ITP). The job is to grade severity, find a reversible cause, and recognise the few that need urgent referral or admission.

Thrombocytopenia โ€“ platelet count Severity Primary-care action
100โ€“149 Mild Often reactive; if isolated, stable and without atypical features, recheck FBC and monitor in primary care.
50โ€“99 Moderate Refer haematology if persistent/unexplained; urgent if age > 60, systemic symptoms, splenomegaly, abnormal FBC, pregnant, or pre-procedure.
20โ€“49 Severe Urgent haematology referral.
< 20 Very severe Same-day admission โ€“ risk of spontaneous bleeding.
Any count + active bleeding โ€“ Same-day assessment/admission regardless of the number.
Thrombocytosis โ€“ platelet count Category Primary-care action
450โ€“600 Mild Usually reactive; check ferritin and CRP, treat the cause, recheck. Pursue cancer pathways (LEGO-C) if symptoms fit.
600โ€“1000 Marked Refer haematology if persistent and unexplained, or symptomatic; suspected-cancer pathway if cancer features.
> 1000 Extreme Urgent haematology โ€“ risk of thrombosis and paradoxical bleeding (acquired von Willebrand syndrome).
Persistent > 450 (confirmed, no reactive cause) โ€“ Routine haematology referral to exclude ET / MPN.
Thrombocytosis + cancer features โ€“ Site-specific suspected-cancer pathway (NICE NG12).

๐Ÿง  Clinical pearl

A raised platelet count can be the only clue to cancer. The cancers most associated with thrombocytosis are remembered as LEGO-C: Lung, Endometrial, Gastric, Oesophageal, Colorectal. In the landmark UK primary-care cohort, roughly a third of patients later diagnosed with lung or colorectal cancer had thrombocytosis with no other referable symptom โ€“ so do not wait for a second red flag before investigating.

Source: NICE NG12 ยท British Society for Haematology


๐Ÿ”’ Sign up free to read the full topic

You're viewing a free preview. Create a free account to unlock the rest.

Sign up free โ†’
Inside the full topic ๐Ÿ”’ History๐Ÿ”’ Red Flags๐Ÿ”’ Examination๐Ÿ”’ Patient Explanation๐Ÿ”’ Investigations๐Ÿ”’ Management๐Ÿ”’ Non-pharmacological Treatment๐Ÿ”’ Pharmacological Treatment๐Ÿ”’ Special Notes๐Ÿ”’ Referral Pathways๐Ÿ”’ Take Home Messages

Sample topics are open to everyone in the Free Sample Bundle.

Part of The Ocean Library, 450+ structured clinical topics mapped to the primary care curriculum. Companion audio in Echo ยท one-page summary in The Scope.

We use cookies to enhance your browsing experience, provide personalised content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Privacy policy